Leaflet NEODOLPASSE solution for infusion
Indicated for: pain and inflammation
Route of administration: infusion
Substance: diclofenac + orphenadrine citrate (nonsteroidal anti-inflammatory drug + analgesic and antipyretic)
ATC: M01AB55 (Musculo-skeletal system | Antiinflammatory and antirheumatic products, non-steroids | Acetic acid derivatives and related substances)
Use caution if you have glaucoma or increased eye pressure.
May cause dry mouth, constipation, urinary retention, or blurred vision.
This medicine may affect the liver.
This medicine may have important interactions with other medicines.
This medicine may affect the kidneys.
Use during pregnancy only on medical advice.
Older people may have an increased risk of side effects.
This medicine may increase the risk of bleeding.
This medicine may cause drowsiness or reduced alertness.
This medicine may increase the risk of ulcer or gastrointestinal bleeding.
The combination of diclofenac and orphenadrine citrate is used for the treatment of pain and inflammation associated with musculoskeletal conditions. Diclofenac is a nonsteroidal anti-inflammatory drug (NSAID), while orphenadrine has muscle relaxant properties.
The medication is administered orally or via injection, as directed by a doctor. It is important to follow the recommended dose to minimize the risk of side effects.
Side effects may include nausea, abdominal pain, dizziness, or drowsiness. In rare cases, severe allergic reactions, gastric ulcers, or renal failure may occur.
This combination is not recommended for patients with active gastric ulcers, severe renal impairment, or hypersensitivity to any of the components.
General data about NEODOLPASSE
- Substance: diclofenac + orphenadrine citrate
- Date of latest medicines list: 01-01-2015
- Product code: W12859003
- Pharmaceutical form: solution for infusion
- Quantity: 10
- Product type: Original
- Prescription status: S - Medicines dispensed with a restricted medical prescription, reserved for use in certain specialized fields.